These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 17453586)

  • 1. Continuation with cotrimoxazole prophylaxis for the prevention of opportunistic infections in HIV-infected persons in rural Zimbabwe: feasibility, obstacles and opportunities.
    Alkatout I; Vineberg R; Schulz U; Anlauf M; Thistle P
    AIDS Care; 2007 Apr; 19(4):478-81. PubMed ID: 17453586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexual behaviour as the limiting and linking factor in HIV-infected people in rural Zimbabwe.
    Alkatout I; Furey A; Vineberg R; Schulz U; Thistle P
    Int J STD AIDS; 2007 Oct; 18(10):688-91. PubMed ID: 17945047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cotrimoxazole prophylaxis in HIV-infected individuals after completing anti-tuberculosis treatment in Thyolo, Malawi.
    Zachariah R; Spielmann MP; Harries AD; Gomani P; Bakali E
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1046-50. PubMed ID: 12546111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection.
    Gill CJ; Sabin LL; Tham J; Hamer DH
    Bull World Health Organ; 2004 Apr; 82(4):290-7. PubMed ID: 15259258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compliance with cotrimoxazole prophylaxis for the prevention of opportunistic infections in HIV-positive tuberculosis patients in Thyolo district, Malawi.
    Zachariah R; Harries AD; Arendt V; Wennig R; Schneider S; Spielmann M; Panarotto E; Gomani P; Salaniponi FM
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):843-6. PubMed ID: 11573896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routinely available cotrimoxazole prophylaxis and occurrence of respiratory and diarrhoeal morbidity in infants born to HIV-infected mothers in South Africa.
    Coutsoudis A; Pillay K; Spooner E; Coovadia HM; Pembrey L; Newell ML
    S Afr Med J; 2005 May; 95(5):339-45. PubMed ID: 15931449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of home-based water chlorination and safe storage on diarrhea among persons with human immunodeficiency virus in Uganda.
    Lule JR; Mermin J; Ekwaru JP; Malamba S; Downing R; Ransom R; Nakanjako D; Wafula W; Hughes P; Bunnell R; Kaharuza F; Coutinho A; Kigozi A; Quick R
    Am J Trop Med Hyg; 2005 Nov; 73(5):926-33. PubMed ID: 16282305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic use of cotrimoxazole against opportunistic infections in HIV-positive patients: knowledge and practices of health care providers in Côte d'Ivoire.
    Brou H; Desgrées-du-Loû A; Souville M; Moatti JP; Msellati P;
    AIDS Care; 2003 Oct; 15(5):629-37. PubMed ID: 12959812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cotrimoxazole prophylaxis for infants exposed to HIV infection.
    Graham SM
    Bull World Health Organ; 2004 Apr; 82(4):297-8. PubMed ID: 15259259
    [No Abstract]   [Full Text] [Related]  

  • 10. Cotrimoxazole prophylaxis for HIV-positive TB patients in developing countries.
    Zachariah R; Massaquoi M
    Trop Doct; 2006 Apr; 36(2):79-82. PubMed ID: 16611438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Provisional WHO/UNAIDS recommendations on the use of contrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa.
    ;
    Afr Health Sci; 2001 Aug; 1(1):30-1. PubMed ID: 12833907
    [No Abstract]   [Full Text] [Related]  

  • 12. Cotrimoxazole prophylaxis in HIV-infected pregnant women: only a first step.
    Heather Watts D; Mofenson LM
    J Infect Dis; 2006 Dec; 194(11):1478-80. PubMed ID: 17083031
    [No Abstract]   [Full Text] [Related]  

  • 13. Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults?
    Hamel MJ; Greene C; Chiller T; Ouma P; Polyak C; Otieno K; Williamson J; Shi YP; Feikin DR; Marston B; Brooks JT; Poe A; Zhou Z; Ochieng B; Mintz E; Slutsker L
    Am J Trop Med Hyg; 2008 Sep; 79(3):320-30. PubMed ID: 18784222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi.
    Mwaungulu FB; Floyd S; Crampin AC; Kasimba S; Malema S; Kanyongoloka H; Harries AD; Glynn JR; Fine PE
    Bull World Health Organ; 2004 May; 82(5):354-63. PubMed ID: 15298226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daily trimethoprim-sulfamethoxazole prophylaxis rapidly induces corresponding resistance among intestinal Escherichia coli of HIV-infected adults in Kenya.
    Chiller TM; Polyak CS; Brooks JT; Williamson J; Ochieng B; Shi YP; Ouma P; Greene C; Hamel M; Vulule J; Bopp C; Slutsker L; Mintz E
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(3):165-9. PubMed ID: 19357424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of a basic care and prevention package by HIV-infected persons in Uganda.
    Colindres P; Mermin J; Ezati E; Kambabazi S; Buyungo P; Sekabembe L; Baryarama F; Kitabire F; Mukasa S; Kizito F; Fitzgerald C; Quick R
    AIDS Care; 2008 Feb; 20(2):139-45. PubMed ID: 17896196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda.
    Bikaako-Kajura W; Luyirika E; Purcell DW; Downing J; Kaharuza F; Mermin J; Malamba S; Bunnell R
    AIDS Behav; 2006 Jul; 10(4 Suppl):S85-93. PubMed ID: 16791525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.
    Kaplan JE; Hu DJ; Holmes KK; Jaffe HW; Masur H; De Cock KM
    Am J Trop Med Hyg; 1996 Jul; 55(1):1-11. PubMed ID: 8702012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
    Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
    J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voluntary counselling, HIV testing and adjunctive cotrimoxazole are associated with improved TB treatment outcomes under routine conditions in Thyolo District, Malawi.
    Chimzizi R; Gausi F; Bwanali A; Mbalume D; Teck R; Gomani P; Zachariah R; Zuza W; Malombe R; Salaniponi FM; Harries AD
    Int J Tuberc Lung Dis; 2004 May; 8(5):579-85. PubMed ID: 15137534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.